Global Autoimmune Disease Diagnosis Market is estimated to be 6.3 Billion by 2025 with a CAGR of 8.9% during the forecasted period.
The global autoimmune disease diagnostics market is driven by growth in public awareness for autoimmune disorders, improved laboratory techniques and automation, growth in partnerships between clinical laboratories and physicians, rise in incidence of diseases such as Graves and Hashimoto's Thyroid Disease and rheumatoid arthritis. The global autoimmune disease diagnosis market accounted for US$ 4.1 billion in 2020 and is estimated to be 6.3 billion by 2025 and is anticipated to register a CAGR of 7.5%. The report. " Global Autoimmune Disease Diagnosis Market, By Product (Consumables & Assay Kits and Instruments), By Test Type (Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test, and Other Tests), By Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, and Other Diseases), By End User (Clinical Laboratories, Hospitals, and Other End Users), and By Region (North America, Europe, Asi